Modified Release Formulations of Lacosamide

摘要

The present invention relates to a modified release formulation comprising lacosamide or a pharmaceutically acceptable salt thereof and an alginate salt or complex salt of alginic acid, together with one or more pharmaceutically acceptable matrix retarding agent.